Danaher Corp.

DHR

$247.19

-6.6% last 12 months

Andreas Halvorsen Holding value: $1.05 Billion Ken Fisher Holding value: $1.01 Billion Daniel Loeb Holding value: $643 Million Al Gore Holding value: $612 Million Chuck Akre Holding value: $443 Million Ken Griffin Holding value: $147 Million Bill Gates Holding value: $92.2 Million PRIMECAP Management Holding value: $62.3 Million Jim Simons Holding value: $60.3 Million Steven Cohen Holding value: $37.4 Million Joel Greenblatt Holding value: $8.16 Million Broad Run Holding value: $5.14 Million Mario Gabelli Holding value: $4.36 Million Ron Baron Holding value: $4.12 Million Ray Dalio Holding value: $2.82 Million Jefferies Group Holding value: $2.02 Million Tom Russo Holding value: $268 Thousand Chuck Royce Holding value: $0 First Eagle Investments Holding value: $0 Baillie Gifford Holding value: $0 Jeremy Grantham Holding value: $0 Julian Robertson Holding value: $0 David Einhorn Holding value: $0 George Soros Holding value: $0

Market Cap

$184 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$220.97 - $282.72

The lowest and highest price in the last 52 weeks.

Price-Earnings Ratio

29.27x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$1.04 (0.42%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Compare to
Market
Industry
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $184 Billion
Enterprise Value A measure of a company's total value. This includes market cap, cash, and debt. $196 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. $1.04 (0.42%)
1 Year Return Profit or loss of share price change plus dividend yield. -6.2%
52-Week High Highest share price in the last 52 weeks. $282.72
52-Week Low Lowest share price in the last 52 weeks. $220.97
Beta Beta indicates the volatility of a stock compared to the market. Higher beta means more volatile and thus potentially higher risk and return. 1.11
Outstanding Shares The number of shares the company has issued and are held by stockholders. 738 Million
Avg 30 Day Volume The number of shares traded in the last 30 days. 2.36 Million

Valuation

Compare to
Market
Industry
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 29.27
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. -87.93
Earnings per Share Earnings divided by outstanding shares. Higher EPS indicates greater value. $8.52
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 6.03
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 3.53
Enterprise Value to Revenue Enterprise value divided by revenue 6.44
Enterprise Value to EBIT Enterprise Value divided by EBIT 25.96
Total Debt to Enterprise Value Total debt divided by enterprise value 0.1
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.38

Profitability

Compare to
Market
Industry
Revenue Revenue is the sum of all cash flow into the company. $30.4 Billion
Gross Profit Gross profit is the profit after subtracting the costs of making and selling its products or the costs of providing its services. It indicates the efficiency of using their resources to produce goods or services. $17.9 Billion
EBIT Earnings before tax and interest payments. $7.53 Billion
Net Income Net Income is the profit after all expenses have been deducted from the total revenue. $6.3 Billion
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 20.74%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -33.3%
Return on Equity Equity divided by market cap. 12.17%
Return on Assets Indicates a company's profitability in relation to its total assets. 7.42%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 9.85%

Insider trades

No purchases

No sells

No purchases

No sells

No purchases

No sells

No purchases

No sells

Q4 2022 Q1 2023 Q2 2023 Q3 2023

About Danaher Corp.

CEO: Rainer Blair

Employees: 2,020

Industry: Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables

Similar stocks

Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
3M Co.
3M Co.
Agilent Technologies Inc.
Agilent Technologies Inc.
Ametek Inc
Ametek Inc
Emerson Electric Co.
Emerson Electric Co.
General Electric Co.
General Electric Co.
Honeywell International Inc
Honeywell International Inc
ABB Ltd. - ADR
ABB Ltd. - ADR
Harvard Bioscience Inc.
Harvard Bioscience Inc.
Align Technology, Inc.
Align Technology, Inc.

News

Abcam founder slams £4.5bn sale to US conglomerate Danaher

Abcam founder slams £4.5bn sale to US conglomerate Danaher

Jonathan Milner blasted the ''low ball'' offer for the Cambridge-based company, which is one of the most successful British biotech firms.

Daily Mail Online Daily Mail Online, 1 day ago
Danaher Bears The Brunt Of Macro Woes: Analyst Flags Lower Demand, Reduced Funding & Weakness In China

Danaher Bears The Brunt Of Macro Woes: Analyst Flags Lower Demand, Reduced Funding & Weakness In China

KeyBanc Capital Markets analyst Paul Knight reiterated the Overweight rating on Danaher Corporation (NYSE: DHR ), lowering the price target to $300 from $325...

Benzinga Benzinga, 2 days ago
Danaher Schedules Third Quarter 2023 Earnings Conference Call

Danaher Schedules Third Quarter 2023 Earnings Conference Call

WASHINGTON, Sept. 26, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the thir...

PR Newswire PR Newswire, 3 days ago
Danaher Lowers Price Of Tuberculosis Test After Pressure Campaign

Danaher Lowers Price Of Tuberculosis Test After Pressure Campaign

Topline Washington D.C.-based drugmaker Danaher has agreed to lower the cost of test cartridges used to diagnose tuberculosis by 20% and sell them at cost, t...

BestNews.com BestNews.com, 10 days ago
Never miss a trade
To improve your user experience we use cookies.